Treatment of Paget's disease of bone.
D000818:Animals; D001862:Bone Resorption / Q000187:drug effects; D002116:Calcitonin / Q000009:adverse effects / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D012968:Etidronic Acid / Q000494:pharmacology / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D010024:Osteoporosis / Q000139:chemically induced; D008926:Plicamycin / Q000627:therapeutic use; D051381:Rats
D003609:Dactinomycin; D002116:Calcitonin; D005934:Glucagon; D012968:Etidronic Acid; D008926:Plicamycin